Varied presentations of cutaneous vasculitis: a case series

Pinky Gupta, Shweta Ganorkar, Surekha Bhalekar, Rajiv Rao


Vasculitis involves a wide spectrum of clinicopathological process with reactive damage to the involved blood vessels. There is loss of vessel integrity instigating haemorrhage & luminal compromise leading to ischemia and necrosis of the tissue supplied by the involved vessels. It may affect varied size and type of blood vessels at different locations. It may be primary or secondary to systemic disease. It may involve a single organ like skin or may involve different organ systems at the same time. This case series include six cases of cutaneous vasculitis affecting different organs with varied presentations. Skin biopsies of six patients with unusual presentations were studied. Their complete history, physical examinations, laboratory investigations including serology were analysed and correlated with histopathological findings. The patients presented with different duration of symptoms varying from as short as 15 days to 1 year. Skin lesions were present in all cases while cardiac manifestation was seen in one. Serology and autoimmune disease markers were negative in all cases except one. However, histopathological features were in concordance with the clinical diagnosis of vasculitis. They were further classified as vasculitis secondary to Churg Strauss syndrome, venous stasis, Henoch Schonlein purpura or leucocytoclastic vasculitis.Vasculitis though a rare disease may manifest as an acute or chronic condition. It needs timely diagnosis by histopathological examination to aid in further management. It is important to assess the clinical severity in primary and secondary vasculitis, as it determines morbidity and mortality.


Churg strauss syndrome, Clinico-pathological process, Cutaneous vasculitis, Henoch schonlein purpura, Leukocytoclastic vasculitis, Vasculitis

Full Text:



Watts RA, Scott DG. Recent developments in the classification and assessment of vasculitis. Best Pract Res Clin Rheumatol. 2009;23:429.

Jennette JC, Falk RJ, Bacon PA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1.

Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512.

Stvrtinova V. Vasculitides of the coronary arteries. Bratisl Lek Listy. 1995;96:544-51

Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-100.

Schwartz RA, Churg J. Churg-Strauss syndrome. Br J Dermatol. 1992;127:199.

Kawakami T, Soma Y, Kawasaki K. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome. Arch Dermatol. 2005;141:873.

Rigamonti F, De Benedetti E, Letovanec I, Rosset A, Chizzolini C. Cardiac involvement in Churg-Strauss syndrome mimicking acute coronary syndrome. Swiss Med Wkly. 2012;142:w13543.

Smedema JP, van Paassen P, van Kroonenburgh MJ, Snoep G, Crijns HJ, Tervaert JW. Cardiac involvement of Churg Strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol. 2004;22:S75-8.

Wagner AD, Meyer GP, Rihl M, Rathmann A, Wittkop U, Zeidler H, et al. Acute coronary syndrome associated with Churg-Strauss syndrome. Vasc Health Risk Manag. 2007;3:775-9.

Tanaka M, Mise N, Kurita N, Suzuki T, Hara K, Fujii A, et al. A case of Churg-Strauss syndrome with necrotizing crescentic glomerulonephritis accompanied by acute coronary syndrome due to vasospasm. Am J Kidney Dis. 2010;56:e5-9.

Conron M, Beynon HL. Churg-Strauss syndrome. Thorax. 2000;55:870.

Zwerina J, Axmann R, Jatzwauk M. Pathogenesis of Churg-Strauss syndrome: recent insights. Autoimmunity. 2009;42:376.

Vaglio A, Martorana D, Maggiore U. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum. 2007 Sep;56(9):3159-66.

Saulsbury FT. Epidemiology of Henoch-Schönlein purpura. Cleve Clin J Med. 2002; 69 Suppl 2:SII87

Calvo-Río V, Loricera J, Mata C, Martín L, Ortiz-Sanjuán F, Alvarez L, et al. Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine. 2014 Mar;93(2):106.

Kang Y, Park JS, Ha YJ, Kang MI, Park HJ, Lee SW, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura. J Korean Med Sci. 2014 Feb 1;29(2):198-203.

Mills JA, Michel BA, Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum. 1990;33:1114.

Rigante D, Castellazzi L, Bosco A, Esposito S. Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura? Autoimmun Rev. 2013;12:1016.

Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337:1512-23.

Sundaresan S, Migden MR, Silapunt S. Stasis Dermatitis: Pathophysiology, Evaluation, and Management. Am J Clin Dermatol. 2017;18:383-90.

Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175-84.

Sippel K, Mayer D, Ballmer B, Dragieva G, Läuchli S, French LE, et al. Evidence that venous hypertension causes stasis dermatitis. Phlebology. 2011; 26:361-5.

Walsh SN, Santa Cruz DJ. Lipodermatosclerosis: a clinicopathological study of 25 cases. J Am Acad Dermatol. 2010;62:1005.

Pappas PJ, DeFouw DO, Venezio LM, Gorti R, Padberg Jr FT, Silva Jr MB, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg. 1997;26:784-95.

Ekenstam E, Callen JP. Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984 Apr 1;120(4):484-9.

Gota CE, Calabrese LH. Diagnosis and treatment of cutaneous leukocytoclastic vasculitis. Int J Clin Rheumatol. 2013;8(1):49-60.

Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56(1):3-23.